Anders Bergman

Sweden; Europe; Northern Europe; Scandinavia
Is it you?
Investor info
Type
Angel Investors / HNW
Stage focus
  • Seed Round
Industry focus
Description
Anders Bergman is an angel investor. Anders is currently a VP at Athera Biotechnologies AB, based in Sweden. Areas of interest include immunovascular disease, clinical stage development, fully human monoclonal antibodies.
Previous investments
  • Company
    Amount
    Round
  • Example example company Inc
    1000000
    Investor meetings
  • Company & Company
    11000000
    Series C funding
  • Example
    524000
    Seed round A
Show more
Connected people
Email visible after logging in
  • Example Example
    Example Exampleexample[email protected]
  • Example Exampleexample
    Example Exampleexample
  • Notexample Examplenot
    Notexample Examplenotexample example[email protected]
  • Example Examplenotexample
    Example Examplenotexampleexample example[email protected]
  • Example Example
    Example Exampleexample[email protected]
  • Example Example
    Example Exampleexample[email protected]
Show more
See other investors focused on
Technology, Media and Telecom (TMT)
Other investors you may be interested in
Made with in San Francisco, Berlin, Valencia, Oslo, Cherkasy and Warsaw© 2015-     Foundersuite, Inc.